Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma.
about
Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical TestingTransgenic Models in Retinoblastoma ResearchEfficient photodynamic therapy on human retinoblastoma cell linesMultimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and developmentSchedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma CellsCRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalisOcular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular RetinoblastomaPharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs.Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.Challenging issues in pediatric oncologyProgress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review.Intravitreal Topotecan Inhibits Laser-induced Choroidal Neovascularization in a Rat Model.Cross-species genomic and epigenomic landscape of retinoblastoma.Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year reviewLessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine.Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235.Retinoblastoma, the visible CNS tumor: A review.
P2860
Q26750379-B68E2AB7-6750-45A6-B089-D2FD1B9F4E7DQ26750411-B223E0AD-15C2-4004-809C-CE7C62DAC9CBQ27324555-0BB26B9B-4459-47F0-AF10-15101DDD0427Q28539433-15731C47-BAB4-4C33-B7F9-C3C2869E9848Q28553176-EF7CCB2B-F4C8-4634-B00A-13619AC4107BQ30822604-696D987B-B2FE-4A0A-B0EF-19424AA207B4Q33437979-A8AD27C5-EDA0-4C5F-A8F0-D1550D2CE164Q34422585-C777294E-1899-4F3A-995B-79437A932FA8Q34802808-E8B83465-9271-48D0-AA2C-C672200059B5Q35050530-18CA4534-83E9-4F8D-9174-05EF234388DDQ35602419-C08E44B7-7E12-47CB-A020-AAD7279D3935Q35706804-35FA344B-C163-4BE6-AD47-01004570E65FQ35749494-758F97CB-61BF-4B35-A4A3-E459DF477F1BQ35884935-FCEF0AC9-F529-4547-8522-E167B07B1B15Q37132228-7B9EF847-7C28-4827-A56A-23760B282192Q37396473-219D9B78-F701-43B4-A151-D833305E7136Q38045441-32300304-C6AC-4DBE-8200-D8CCDA7A8A44Q38182072-9A5922A2-9267-479D-824C-7D2CC81F14EAQ38938719-3630E69B-4F05-409F-ABF9-AF3ABE53E96BQ40970798-C8856019-DACD-4E22-9EC0-6E0046E9056DQ48288706-BAA878F2-E5EE-4111-BD1B-9A39ABC58369
P2860
Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@ast
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@en
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@nl
type
label
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@ast
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@en
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@nl
prefLabel
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@ast
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@en
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Subconjunctival carboplatin an ...... ical models of retinoblastoma.
@en
P2093
Clinton Stewart
Jiakun Zhang
Katie M Nemeth
Merrill Egorin
Michael A Dyer
Paula Schaiquevich
Sara Federico
P2860
P304
P356
10.1002/CNCR.25574
P407
P577
2010-09-03T00:00:00Z